Regenxbio (RGNX) Other Non-Current Liabilities (2018 - 2026)

Regenxbio's Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $638000.0 for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities fell 82.45% year-over-year to $638000.0; the TTM figure through Dec 2025 stood at $638000.0 (down 82.45% YoY), while the FY2025 annual figure was $638000.0, down 82.45% from the prior year.
• Other Non-Current Liabilities for Q4 2025 stood at $638000.0, down from $648000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $171.3 million in Q4 2021, with the low at $448000.0 in Q1 2021.
• The 5-year median for Other Non-Current Liabilities is $6.9 million (2022), against an average of $37.5 million.
• The sharpest annual moves came in 2021 and 2025: Other Non-Current Liabilities surged 26379.82% in 2021, then tumbled 98.15% in 2025.
• Regenxbio's Other Non-Current Liabilities stood at $171.3 million in 2021, then slipped by 19.69% to $137.6 million in 2022, then plunged by 68.4% to $43.5 million in 2023, then slumped by 91.64% to $3.6 million in 2024, then plunged by 82.45% to $638000.0 in 2025.
• Business Quant data shows RGNX's Other Non-Current Liabilities at $638000.0 in Q4 2025, $648000.0 in Q3 2025, and $664000.0 in Q2 2025.